# Venetoclax in Combination With ASTX727 for the Treatment of Chronic Myelomonocytic Leukemia and Other Myelodysplastic Syndrome/Myeloproliferative Neoplasm

> clinical trial · VERIFIED · 2026-07-31

Status: ACTIVE_NOT_RECRUITING · Sponsor: National Cancer Institute (NCI) · Condition: Chronic Myelomonocytic Leukemia

- Company: National Cancer Institute (NCI)
- Sector: Chronic Myelomonocytic Leukemia
- Primary source: https://clinicaltrials.gov/study/NCT05600894

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.